Omacor; omega-3-acid ethyl ester 90 (N-3 PUFA) and risk faktors in HIV infected patients treated with HAART with special focus on lipids.
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2014
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Sponsors Pronova BioPharma
- 10 Jun 2017 Biomarkers information updated
- 14 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2011 New trial record